Published in Curr Treat Options Oncol on August 15, 2008
Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol (2010) 2.95
Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci U S A (2010) 1.72
Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg (2012) 1.67
Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res (2012) 1.61
Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies. Radiology (2013) 1.39
The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Part Fibre Toxicol (2012) 1.31
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res (2010) 1.22
Computerized segmentation and measurement of malignant pleural mesothelioma. Med Phys (2011) 1.16
HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts. PLoS One (2011) 1.12
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn (2010) 1.09
Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways. Mol Cancer Res (2012) 1.06
Lung cancer: Biology and treatment options. Biochim Biophys Acta (2015) 1.02
Utilization of gene profiling and proteomics to determine mineral pathogenicity in a human mesothelial cell line (LP9/TERT-1). J Toxicol Environ Health A (2010) 1.02
Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib. PLoS One (2010) 1.02
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma. Oncogene (2011) 0.93
The interaction of asbestos and iron in lung tissue revealed by synchrotron-based scanning X-ray microscopy. Sci Rep (2013) 0.89
Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway. Int J Oncol (2011) 0.89
Overview of the biochemical and genetic processes in malignant mesothelioma. J Bras Pneumol (2014) 0.88
Telomerase activity in pleural malignant mesotheliomas. Lung Cancer (2011) 0.86
Chronic exposure to carbon nanotubes induces invasion of human mesothelial cells through matrix metalloproteinase-2. ACS Nano (2013) 0.86
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod Pathol (2015) 0.85
Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells. PLoS One (2012) 0.85
NLRP1 polymorphisms in patients with asbestos-associated mesothelioma. Infect Agent Cancer (2012) 0.85
French cohort of the uranium processing workers: mortality pattern after 30-year follow-up. Int Arch Occup Environ Health (2009) 0.82
Reactive oxygen species a double-edged sword for mesothelioma. Oncotarget (2015) 0.82
Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma. Br J Cancer (2013) 0.82
Meeting report: mode(s) of action of asbestos and related mineral fibers. Environ Health Perspect (2011) 0.81
Malignant peritoneal mesothelioma presenting with persistent high fever. J Zhejiang Univ Sci B (2011) 0.81
Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis. Oncotarget (2016) 0.80
A case report of an extremely rare and aggressive tumor: primary malignant pericardial mesothelioma. Rare Tumors (2012) 0.80
Spontaneous mesotheliomas in F344/N rats are characterized by dysregulation of cellular growth and immune function pathways. Toxicol Pathol (2013) 0.80
The endoplasmic reticulum mitochondrial calcium cross talk is downregulated in malignant pleural mesothelioma cells and plays a critical role in apoptosis inhibition. Oncotarget (2015) 0.80
Flaxseed lignans enriched in secoisolariciresinol diglucoside prevent acute asbestos-induced peritoneal inflammation in mice. Carcinogenesis (2015) 0.79
A rare cause of heart failure with preserved ejection fraction: primary pericardial mesothelioma masquerading as pericardial constriction. BMJ Case Rep (2014) 0.79
Distinctive clinical characteristics of malignant mesothelioma in young patients. Oncotarget (2015) 0.78
Parakeratotic-like cells in effusions - A clue to diagnosis of malignant mesothelioma. Cytojournal (2012) 0.78
Primary pericardial mesothelioma: a rare entity. Case Rep Oncol Med (2013) 0.78
The assessment of the malignant mesothelioma cases and environmental asbestos exposure in Sivas province, Turkey. Environ Geochem Health (2013) 0.77
Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure. Eur J Cardiothorac Surg (2012) 0.77
The Emerging Role of TRAF7 in Tumor Development. J Cell Physiol (2016) 0.77
Receptor role of the annexin A2 in the mesothelial endocytosis of crocidolite fibers. Lab Invest (2015) 0.77
The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesothelioma. J Clin Pathol (2012) 0.76
Clinicopathologic and survival characteristics of malignant pleural mesothelioma registered in hospital cancer registry. Tanaffos (2014) 0.75
Diagnostic delay in malignant pleural mesothelioma due to physicians fixation on history with non-exposure to asbestos. BMJ Case Rep (2013) 0.75
Conjunctival Metastasis from Pleural Mesothelioma. Ocul Oncol Pathol (2014) 0.75
Sarcomatoid Type Primary Pericardial Mesothelioma with a Long-term Survival after the Onset of Cardiac Tamponade. Intern Med (2016) 0.75
Clinical and prognostic features of erionite-induced malignant mesothelioma. Yonsei Med J (2015) 0.75
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration. Cancer Biol Ther (2016) 0.75
Simian virus 40 may be associated with developing malignant pleural mesothelioma. Oncol Lett (2016) 0.75
MRI assessment of cardiac tumours: part 2, spectrum of appearances of histologically malignant lesions and tumour mimics. Quant Imaging Med Surg (2014) 0.75
Chest neoplasms with infectious etiologies. World J Radiol (2011) 0.75
Epidemiology of mesothelioma in Egypt. A ten-year (1998-2007) multicentre study. Arch Med Sci (2010) 0.75
Network of microRNA, transcription factors, target genes and host genes in human mesothelioma. Exp Ther Med (2017) 0.75
A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma. Lung Cancer (Auckl) (2017) 0.75
Advances in malignant mesothelioma. N Engl J Med (2005) 8.50
The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg (2000) 4.96
Malignant mesothelioma. Lancet (2005) 3.93
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst (2005) 3.73
Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol (2004) 3.28
Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health (2007) 2.48
TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci U S A (2006) 2.14
Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med (2003) 2.13
p21-activated kinase links Rac/Cdc42 signaling to merlin. J Biol Chem (2001) 2.05
Peritoneal mesothelioma: a review. MedGenMed (2007) 2.01
Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A (2000) 1.91
The pathogenesis of mesothelioma. Semin Oncol (2002) 1.80
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nat Rev Cancer (2007) 1.61
The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Mol Cell Biol (2005) 1.60
Post-irradiation malignant mesothelioma. Cancer (1996) 1.52
Malignant pleural mesothelioma: a comprehensive review. Cancer Control (2006) 1.47
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol (2001) 1.41
A mouse model recapitulating molecular features of human mesothelioma. Cancer Res (2005) 1.39
Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK. Oncogene (2006) 1.38
Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J Cell Physiol (1999) 1.38
Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci U S A (2006) 1.37
Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression. Cancer Res (2002) 1.33
SV40 and human tumours: myth, association or causality? Nat Rev Cancer (2002) 1.29
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci U S A (2001) 1.29
Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res (2005) 1.29
The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res (2008) 1.25
Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene (2003) 1.25
Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health (2005) 1.22
New developments about the association of SV40 with human mesothelioma. Oncogene (2003) 1.22
Interleukin 8: an autocrine growth factor for malignant mesothelioma. Cancer Res (1999) 1.18
Pleural macrophage recruitment and activation in asbestos-induced pleural injury. Environ Health Perspect (1997) 1.15
Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implication from mutation patterns induced by reactive oxygen species. Environ Health Perspect (2002) 1.13
A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent. Cancer Res (2006) 1.11
Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century. Int J Tuberc Lung Dis (2007) 1.10
Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. Occup Environ Med (2003) 1.08
New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst (2002) 1.03
SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells. Cancer Res (2007) 1.02
SV40 infection induces telomerase activity in human mesothelial cells. Oncogene (2002) 1.01
Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem (1999) 0.98
Chrysotile as a cause of mesothelioma: an assessment based on epidemiology. Crit Rev Toxicol (2006) 0.97
Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res (2000) 0.97
Current concepts in malignant pleural mesothelioma. Expert Rev Anticancer Ther (2008) 0.95
SV40 and cell cycle perturbations in malignant mesothelioma. Semin Cancer Biol (2001) 0.95
Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer (2007) 0.95
Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors. Anticancer Res (2004) 0.94
Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure. Inhal Toxicol (2005) 0.93
Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies. Future Oncol (2008) 0.92
The role of environmental carcinogens, viruses and genetic predisposition in the pathogenesis of mesothelioma. Cancer Biol Ther (2002) 0.89
Pathogenesis of malignant mesothelioma. Clin Lung Cancer (2004) 0.86
Malignant mesothelioma of the pleural space. Oncology (Williston Park) (1999) 0.85
Evidence of an important role for SV40 in mesothelioma. Thorac Surg Clin (2004) 0.83
The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer (2006) 0.83
Diffuse malignant mesothelioma of the peritoneum following abdominal radiotherapy. Eur J Surg Oncol (2001) 0.82
Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status. Int J Cancer (1995) 0.80
Malignant mesothelioma: current conundrums over risk estimates and whither electron microscopy for diagnosis? Ultrastruct Pathol (1997) 0.79
Perturbations of the AKT signaling pathway in human cancer. Oncogene (2005) 6.64
Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet (2011) 4.26
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med (2005) 4.11
Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell (2010) 3.79
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med (2012) 3.52
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg (2008) 2.93
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene (2004) 2.67
Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med (2002) 2.56
BAP1 and cancer. Nat Rev Cancer (2013) 2.23
TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci U S A (2006) 2.14
p21-activated kinase links Rac/Cdc42 signaling to merlin. J Biol Chem (2001) 2.05
Chromosomal imbalances in human lung cancer. Oncogene (2002) 2.00
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci U S A (2008) 1.97
High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol (2015) 1.93
Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis (2004) 1.92
T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. Cancer Cell (2010) 1.85
A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor. Cancer J (2004) 1.85
GIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signaling. Mol Cell Biol (2006) 1.85
The pathogenesis of mesothelioma. Semin Oncol (2002) 1.80
APPL1 associates with TrkA and GIPC1 and is required for nerve growth factor-mediated signal transduction. Mol Cell Biol (2006) 1.78
RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Cancer Res (2007) 1.76
Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci U S A (2010) 1.72
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model. Clin Cancer Res (2007) 1.72
Cancer and inflammation: promise for biologic therapy. J Immunother (2010) 1.72
Frequent activation of AKT2 kinase in human pancreatic carcinomas. J Cell Biochem (2002) 1.70
Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res (2012) 1.61
Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling. Am J Pathol (2013) 1.61
The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Mol Cell Biol (2005) 1.60
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer Biol Ther (2004) 1.58
Cellular and molecular parameters of mesothelioma. J Cell Biochem (2006) 1.57
Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res (2004) 1.51
Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene (2005) 1.48
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. J Clin Oncol (2007) 1.46
AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival. Oncogene (2002) 1.44
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth. Oncogene (2005) 1.41
A mouse model recapitulating molecular features of human mesothelioma. Cancer Res (2005) 1.39
mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary. Clin Cancer Res (2009) 1.39
Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice. Proc Natl Acad Sci U S A (2009) 1.38
Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci U S A (2006) 1.37
Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res (2006) 1.35
Diverse mechanisms of AKT pathway activation in human malignancy. Curr Cancer Drug Targets (2013) 1.33
Asbestos is not just asbestos: an unrecognised health hazard. Lancet Oncol (2013) 1.33
SV40 and human tumours: myth, association or causality? Nat Rev Cancer (2002) 1.29
Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res (2005) 1.29
Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood (2012) 1.29
Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med (2011) 1.27
Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Ann Thorac Surg (2008) 1.26
Retracted Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene (2005) 1.25
The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res (2008) 1.25
Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene (2003) 1.25
Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One (2012) 1.24
The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern Nevada. J Thorac Oncol (2015) 1.24
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res (2010) 1.22
Human follicle-stimulating hormone (FSH) receptor interacts with the adaptor protein APPL1 in HEK 293 cells: potential involvement of the PI3K pathway in FSH signaling. Biol Reprod (2004) 1.21
Serine/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance. Cancer Res (2004) 1.20
A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice. Cancer Res (2008) 1.19
Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome. Genes Chromosomes Cancer (2011) 1.18
Protein kinase C phosphorylation disrupts Na+/H+ exchanger regulatory factor 1 autoinhibition and promotes cystic fibrosis transmembrane conductance regulator macromolecular assembly. J Biol Chem (2007) 1.18
FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis. Cell Cycle (2009) 1.15
Current status of screening for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg (2009) 1.14
Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol (2010) 1.12
A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities. Cancer Biol Ther (2004) 1.11
Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype. Oncogene (2004) 1.11
SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure. Cancer Res (2005) 1.11
High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes Chromosomes Cancer (2009) 1.10
Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts. Endocrinology (2002) 1.09
Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation. J Biol Chem (2002) 1.08
Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model. Ann N Y Acad Sci (2010) 1.08
Activated cAMP response element binding protein is overexpressed in human mesotheliomas and inhibits apoptosis. Am J Pathol (2009) 1.07
Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways. Mol Cancer Res (2012) 1.06
Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Clin Cancer Res (2004) 1.06
Appl1 is dispensable for mouse development, and loss of Appl1 has growth factor-selective effects on Akt signaling in murine embryonic fibroblasts. J Biol Chem (2009) 1.06
HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway. Am J Respir Cell Mol Biol (2007) 1.05
A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results. Ann Thorac Surg (2008) 1.04
Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin. Mol Cancer (2010) 1.04
Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE). Lung Cancer (2004) 1.03
Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer. Mol Cell Biol (2009) 1.03
Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer. Clin Cancer Res (2004) 1.02
Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy. Int J Cancer (2010) 1.02
Malignant pleural mesothelioma. Curr Probl Cancer (2004) 1.01
SV40 infection induces telomerase activity in human mesothelial cells. Oncogene (2002) 1.01
ERK2 is essential for the growth of human epithelioid malignant mesotheliomas. Int J Cancer (2011) 1.00
Cytogenetics and molecular genetics of lung cancer. Am J Med Genet (2002) 1.00
Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer (2003) 0.99
CD45-deficient severe combined immunodeficiency caused by uniparental disomy. Proc Natl Acad Sci U S A (2012) 0.99
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis. PLoS One (2011) 0.99
Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett (2002) 0.98
Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma. Cancer Genet (2013) 0.97
A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. Cancer Res (2008) 0.97
Retracted Identification of Akt interaction protein PHF20/TZP that transcriptionally regulates p53. J Biol Chem (2012) 0.97